SPRB Spruce Biosciences, Inc.
Healthcare$51.92+0.00%OpenMarket Cap: $71.2M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
2.02
P/S
0.00
EV/EBITDA
-0.63
DCF Value
$61.81
FCF Yield
-41.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-155.4%
ROA
-66.2%
ROIC
-74.4%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | NaN% | $-12.0M | $-12.3M | $— | — |
| Q4 null | $0.00 | NaN% | $-11.1M | $-14.6M | $— | — |
| FY null | $0.00 | NaN% | $-36.5M | $-39.0M | $— | — |
| Q3 null | $0.00 | NaN% | $-8.2M | $-8.2M | $— | — |
| Q2 null | $0.00 | NaN% | $-2.7M | $-2.1M | $— | — |
| Q1 null | $0.00 | NaN% | $-14.5M | $-14.0M | $— | — |
| Q4 null | $697.0K | 100.0% | $-24.1M | $-23.6M | $— | — |
| FY null | $4.9M | 100.0% | $-56.2M | $-53.0M | $— | — |
| Q3 null | $602.0K | 100.0% | $-9.4M | $-8.7M | $— | — |
| Q2 null | $1.6M | 100.0% | $-10.0M | $-9.2M | $— | — |
| Q1 null | $2.0M | 100.0% | $-12.6M | $-11.6M | $— | — |
| Q4 2023 | $2.9M | 99.4% | $-11.2M | $-9.9M | $-18.00 | — |